The cost of weight-loss drugs should fall in 2026
A drastic surge in demand has put drugs like Wegovy, Victoza and Ozempic in short supply Michael Siluk/Alamy The blockbuster weight-loss drug semaglutide and its rivals promise to help reverse the global obesity epidemic – if only more of the people who would benefit from these treatments could afford them. But this year could see…
